Antonelli Financial Advisors LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 3.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,440 shares of the healthcare conglomerate’s stock after selling 51 shares during the quarter. UnitedHealth Group comprises about 0.6% of Antonelli Financial Advisors LLC’s investment portfolio, making the stock its 24th biggest holding. Antonelli Financial Advisors LLC’s holdings in UnitedHealth Group were worth $754,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of the business. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $28,000. Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $30,000. Finally, Promus Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth $32,000. Institutional investors own 87.86% of the company’s stock.
Insider Buying and Selling
In related news, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction that occurred on Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director now directly owns 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO John F. Rex purchased 17,175 shares of the firm’s stock in a transaction on Friday, May 16th. The stock was bought at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer now owns 203,796 shares of the company’s stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders acquired 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company’s stock.
UnitedHealth Group Stock Down 1.7%
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the prior year, the business earned $6.91 earnings per share. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be paid a dividend of $2.21 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.93%. UnitedHealth Group’s dividend payout ratio is currently 37.02%.
Wall Street Analyst Weigh In
A number of analysts have commented on UNH shares. TD Cowen cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price for the company. in a report on Monday, May 19th. Bank of America cut UnitedHealth Group from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $560.00 to $350.00 in a research report on Wednesday, May 14th. Wolfe Research decreased their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 20th. Robert W. Baird cut shares of UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price objective for the company. in a research note on Wednesday, June 11th. Finally, HSBC reaffirmed a “reduce” rating and issued a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $427.09.
Get Our Latest Stock Report on UNH
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- The Boring Is Beautiful Portfolio: 3 Stocks for a Worried World
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- More Than a Monetary Metal: Silver’s Case for Outperformance
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Retail Sales Signal Upside for These 3 Consumer Stocks
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.